help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Middendorff, R.
Right arrow Articles by Davidoff, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Middendorff, R.
Right arrow Articles by Davidoff, M. S.
The Journal of Clinical Endocrinology & Metabolism Vol. 82, No. 12 4154-4161
Copyright © 1997 by The Endocrine Society


Original Studies

Evidence for Production and Functional Activity of Nitric Oxide in Seminiferous Tubules and Blood Vessels of the Human Testis1

R. Middendorff, D. Müller, S. Wichers, A. F. Holstein and M. S. Davidoff

Institute of Anatomy (R.M., S.W., A.F.H., M.S.D.) and Institute for Hormone and Fertility Research (D.M.), University of Hamburg, 20246 Hamburg, Germany

Address all correspondence and requests for reprints to: Dr. Ralf Middendorff, Institute of Anatomy, University of Hamburg, Martinistraße 52, 20246 Hamburg, Germany.


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Previous studies have demonstrated that nitric oxide (NO) influences Leydig cell function. Here we provide evidence for NO production and activity in seminiferous tubules and blood vessels of the human testis. By immunohistochemistry, the soluble guanylyl cyclase (sGC), the intracellular NO receptor, and the second messenger, cyclic guanosine monophosphate (cGMP), were detected in myofibroblasts of the peritubular lamina propria in Sertoli cells, as well as in endothelial and smooth muscle cells of testicular blood vessels. Performed with isolated tubules and blood vessels, the biological activity of sGC could be proved by cGMP generation in response to treatments with the NO donor, sodium nitroprusside. The endothelial and neuronal subtypes of NO synthase (NOS) were localized immunohistochemically to the same cell types that express sGC and cGMP. In isolated tubules and vessels, the presence of endothelial NOS and neuronal NOS was confirmed by immunoblotting, and NOS activity was demonstrated by decreased cGMP production upon incubation with the NOS inhibitor L-nitro arginine methylester. These findings show that peritubular cells, Sertoli cells, and testicular blood vessels may be sites of NO production and activity, possibly involved in relaxation of seminiferous tubules and blood vessels to modulate sperm transport and testicular blood flow, respectively.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
THE MESSENGER molecule, nitric oxide (NO), is an unusual mediator because it diffuses freely across membranes and is extremely labile, with a biological half-life (t1/2) of few seconds. In target cells, NO binds to and activates a soluble heme-containing guanylyl cyclase (sGC), resulting in increased levels of the second messenger, cyclic guanosine monophosphate (cGMP) (1, 2, 3, 4). Thus, sGC, which consists of two subunits ({alpha}1 and ß1), seems to be necessary for NO function (1). NO serves as a neurotransmitter in the nervous system and as a mediator of endothelium-dependent relaxation of blood vessels and mediates the tumoricidal and bactericidal actions of macrophages (5, 6). Three different subtypes of the enzyme NO synthase (NOS) [a neuronal (nNOS), an endothelial (eNOS), and an inducible or macrophageal (iNOS) form] are known and all of them are capable of producing NO (7).

NOS activity was found to be present in male reproductive organs (8, 9). In Leydig cells of the human testis, nNOS (10) and a functionally active sGC (11) have been detected. Furthermore, an inhibitory effect of NO on testosterone secretion by rat Leydig cells has been described (12, 13).

In the human testis, Leydig cells are in close relationship with the peritubular lamina propria on the one hand (14) and with testicular blood vessels on the other hand (15). Both (blood vessels and the peritubular lamina propria) possess contractile elements; namely, vascular smooth-muscle cells (15, 16) and the myofibroblasts of the inner 3–5 layers of the peritubular lamina propria (14, 17, 18, 19).

Because NO was first described as a smooth muscle-relaxing factor (reviewed in Refs. 2–6), it is possible that NO, produced by Leydig cells, may counterbalance contractions of neighboring vascular myocytes and peritubular myofibroblasts.

The present report shows that NO-producing enzymes (NOS) and NO receptors are not only present in Leydig cells but also in peritubular lamina propria, Sertoli, and blood vessel cells, suggesting production and activity of NO in these structures.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Subjects

Testes were obtained from 14 patients, 30–86 yr old, who were undergoing orchiectomy as the primary treatment of prostatic carcinoma.

Isolation of seminiferous tubules and testicular blood vessels

One to 2 h after surgery, pieces of chilled human testes were transferred to dishes containing Ham’s F12/DMEM culture medium (Gibco, Eggenstein, Germany) supplemented with 15 mmol/L NaHCO3, 20 mmol/L HEPES (pH 7.4), 100 IU/mL penicillin, 100 µg/mL streptomycin, 2.5 µg/mL amphotericin B, 10 µg/mL transferrin, 5 µg/mL hydrocortisone, and 2% FBS. Seminiferous tubules were then exposed as described (20). Blood vessels were pulled off from the connective tissue. Isolated tubules and vessels were either frozen in liquid nitrogen or transferred to 24-well microtiter plates (approximately 100 mg/well) containing the above mentioned culture medium.

Protein preparation

Frozen testicular blood vessels and seminiferous tubules were pulverized in a mortar, suspended in 9 mL homogenization buffer (0.05 mol/L Tris-HCl (pH 7.5) containing 10 mmol/L EDTA, 10 mmol/L dithiothreitol, and 0.1 mmol/L phenyl methyl sulfonyl fluoride) and homogenized by three strokes in a Potter-Elvehjem homogenizer. After centrifugation at 3,000 x g for 8 min to remove cell debris and nuclei, the supernatant fractions were centrifuged for 30 min at 100,000 x g. The resulting supernatant fractions, referred to as cytosolic extracts, were stored at -70 C, and the crude membrane pellets were washed once each in homogenization buffer plus 0.6 mol/L KCl, in homogenization buffer and were finally resuspended in 150 µL of 0.05 mol/L Tris-HCl buffer (pH 7.5). Protein concentration was determined with a Bio-Rad kit (Munich, Germany) using BSA (fraction V) as standard.

Immunoblotting

After separation by SDS-PAGE in 8% acrylamide gels, proteins (individual preparations from six different testes) were transferred to nitrocellulose membranes (Amersham, Braunschweig, Germany) at room temperature for 18 h at 12 V in transfer buffer containing 100 mmol/L Tris base and 193 mmol/L glycine. The transferred proteins were visualized by staining with Ponceau S (Sigma, Deisenhofen, Germany), and the membranes were incubated for 2 h in a solution containing 1% blocking reagent (Boehringer, Mannheim, Germany) in 0.1 mol/L maleic acid, 0.15 mol/L NaCl, and 0.005% thimerosal adjusted to pH 7.5. After washing for 5 min in tris-buffered saline plus Tween (20 mmol/L Tris (pH 7.6), 137 mmol/L NaCl, 0.05% Tween 20), the proteins were incubated with monoclonal mouse (anti-nNOS, diluted 1:500; anti-eNOS, 1:100; anti-iNOS, 1:2,500; all purchased from Transduction, Lexington, KY) or polyclonal rabbit (directed against the {alpha}1-subunit of sGC, 1:200, kindly provided by D. Koesling, Berlin, Germany) antibodies for 1 h at room temperature, rinsed twice for 10 min in tris-buffered saline plus Tween, and then incubated with antimouse IgG, linked to peroxidase (Pierce, Rockford, IL, 1:2,000) or antirabbit IgG-peroxidase (Sigma, 1:500). Enhanced chemiluminescence fluorography, performed with enhanced chemiluminescence fluorography-detection reagents from Amersham, according to the manufacturer’s instructions, and Medical X-ray film (Fuji) were used for the detection of bound secondary antibodies.

Immunohistochemistry

Tissue blocks derived from 14 human testes were used. Cryostat sections (10 µm), washed in 2% saponin in PBS and fixed with 4% paraformaldehyde in PBS, as well as paraffin sections (6 µm) prepared as described previously (10, 11), were mounted onto chrome-gelatin precoated slides. On paraffin sections, the following rabbit polyclonal antisera were employed: anti-nNOS (Biomol, Hamburg, Germany; working dilution 1:500), anti-cGMP (Biogenesis, Sandown, NH; 1:300), and anti-sGC (1:200; see above). Rabbit polyclonal anti-eNOS (Biomol, 1:500) and anti-iNOS (Biomol, 1:500) were used on cryostat sections. For visualization of immunoreactivity (IR), a combination of the peroxidase antiperoxidase with the avidin-biotin-peroxidase procedure was used (10, 11).

For negative controls, sections were used in which primary, secondary, or tertiary antibodies were replaced by PBS and in which only the development of the enzyme activity (peroxidase) was performed. Furthermore, sections were incubated with normal rabbit or mouse serum (Sigma), as well as with purified rabbit or mouse IgGs (Sigma), instead of the primary antisera. In addition, anti-nNOS and anti-sGC antisera were preadsorbed to the corresponding antigens (20 µg nNOS/mL anti-nNOS, 1:500; 10 µg {alpha}1 sGC/mL anti-sGC, 1:200); and anti-eNOS and anti-iNOS antisera were preadsorbed to lysates from either endothelial cells or macrophages, known to contain eNOS and iNOS, respectively, and delivered by one of the manufacturers of the antibodies (Transduction) to serve as positive controls. For positive controls, antisera were used on rat brain sections, where immunohistochemical data for cGMP, sGC, eNOS, and nNOS are already available (21, 22, 23). As further evidence for reaction specificity, primary antibodies were replaced by differently generated ones [mouse monoclonal anti-nNOS, 1:500; anti-eNOS, 1:100; and anti-iNOS, 1:500 (all purchased from Transduction) and rabbit polyclonal anti-cGMP, 1:500 (kindly provided by J. DeVente, Maastricht, The Netherlands)].

Measurement of cGMP production by isolated seminiferous tubules and blood vessels

After 1 day of culture (see above) at 34 C (5% CO2/95% O2), the medium was removed; and tubule and vessel preparations (testes from five patients, four different tubule and vessel preparations from each testis) were washed twice in Locke’s salt solution (154 mmol/L NaCl, 5.6 mmol/L KCl, 2.2 mmol/L CaCl2, 1 mmol/L MgCl2, 6 mmol/L NaHCO3, 10 mmol/L glucose, 2 mmol/L HEPES, pH 7.4) supplemented with 20 µmol/L bacitracin. To measure the effects of sodium nitroprusside (SNP) and of L-nitro arginine methyl ester (L-NAME) on cGMP production, the vessels and tubules, respectively, were first incubated for 1 h at 34 C in 250 µL Locke’s solution containing additionally 0.25 mmol/L 3-isobutyl-1-methyl-xanthine (IBMX, purchased from Sigma) in the absence and then in the presence of either 1 mmol/L SNP (purchased from Sigma) or 1 mmol/L L-NAME (Sigma). Solutions were removed after each incubation, immediately frozen in liquid nitrogen, and stored at -70 C until use in the cGMP RIA.

cGMP was measured, as described (24), with RIA reagents kindly provided by IBL (Hamburg, Germany). The minimum detection limit was 10 fmol/tube and cross-reactivity with cAMP was less than 0.001%.

All measurements of cGMP were performed in triplicate. Treatment effects, based on 20 different experiments [each in the absence or presence of SNP (see Fig. 7aGo) and L-NAME (see Fig. 7bGo), respectively] were assessed statistically using t test as installed in the GraphPad InStat Software (GraphPad Inc., Sorrento, CA), with P <= 0.05 as the criterion of significance. The results (see Fig. 7Go) are mean ± SE (SEM) of treatment effects of all experiments performed with tubule and vessel preparations, respectively.



View larger version (14K):
[in this window]
[in a new window]
 
Figure 7. Effects of the NO donor SNP (a) and of the NOS inhibitor L-NAME (b) on cGMP production by isolated blood vessels and seminiferous tubules. Four different preparations each of vessels and tubules from 5 testes were incubated in the presence of 0.25 mmol/L IBMX with either 1 mmol/L SNP (a) or 1 mmol/L L-NAME (b) for 1 h. Incubations in the absence of SNP and L-NAME were used to assess basal sGC activities (control). The data presented are mean ± SE of 20 different experiments. SNP- and L-NAME-dependent cGMP productions differed significantly (P <= 0.05) from controls. SNP-induced cGMP production is indicated as -fold stimulation vs. control and L-NAME-induced inhibition of cGMP production as % of control.

 

    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
To determine whether the receptor for NO, the sGC, as well as the NO-producing enzymes eNOS and nNOS are present in blood vessels and seminiferous tubules of the human testis, we performed immunoblots on cytosolic and crude membrane protein fractions of isolated vessels and tubules. The {alpha}1-subunit of sGC, 82 kDa in size (1), could be demonstrated in the cytosolic protein extracts of human testicular vessels and tubules (Fig. 1aGo). The presence of nNOS was analyzed in parallel immunoblots. A single protein migrating at approximately 160 kDa (Fig. 1bGo), the molecular mass of nNOS on denaturing SDS-polyacrylamide gels (7, 22), was found in cytosolic protein fractions of blood vessels and seminiferous tubules of the human testis and in extracts of a rat pituitary tumor cell line delivered as positive control by the manufacturer of the anti-nNOS antibody. eNOS-IR, migrating with an electrophoretic mobility equivalent to 135 kDa (7, 22), was detected in crude membrane protein fractions of testicular vessels and tubules (Fig. 1cGo). Aortic endothelial cells, known to possess eNOS (4), served as positive control.



View larger version (79K):
[in this window]
[in a new window]
 
Figure 1. Western blot analyses for sGC (a), nNOS (b), and eNOS (c) in blood vessels and seminiferous tubules of the human testis. IR for the {alpha}1-subunit of sGC, migrating at approximately 82 kDa, was detected in cytosolic fractions (80 µg of protein) of testicular vessels and tubules. Rat brain extracts (60 µg protein), known to contain sGC (22), were used for reference. nNOS-IR, equivalent to 160 kDa, was observed in cytosolic extracts (80 µg protein) of vessels, tubules, and rat pituitary tumor cells (1.2 µg protein), the latter being used as positive control. A protein of 135 kDa was demonstrated by the use of anti-eNOS antibodies in crude membrane fractions (80 µg protein) of blood vessels and seminiferous tubules, respectively. Extracts of human aortic endothelial cells (3.2 µg protein) served as positive control. Signals representing the antigens are marked by arrows. The migration of molecular mass markers (Sigma SDS-6H) is indicated.

 
Immunohistochemical investigations were carried out to localize more exactly sGC, the second messenger cGMP, and the NO-producing enzymes. IR for sGC was observed in endothelial and smooth muscle cells of a subpopulation of arterioles and arteries (Fig. 2aGo). IR for cGMP was found within endothelial cells of small blood vessels (Fig. 2bGo), whereas in large blood vessels, cGMP-IR was additionally detected in smooth-muscle cells (Fig. 2cGo). Staining of testicular veins was not observed. A subpopulation of peritubular myofibroblasts (Fig. 3aGo) showed a positive staining for sGC. Some lamina propria cells of all layers showed cGMP-IR (Fig. 3bGo).



View larger version (178K):
[in this window]
[in a new window]
 
Figure 2. sGC- and cGMP-IR in blood vessels of the human testis (x820). A small (diameter < 35 µm) artery showed strong sGC-IR in endothelial (arrow), as well as in smooth muscle (arrowhead) cells (a). cGMP-IR was located in endothelial cells (arrow) of a small (diameter < 35 µm) testicular blood vessel (b) and in the endothelial (arrow), as well as in the muscle layer (arrowhead), of an artery (c) with a large diameter (65 µm).

 


View larger version (119K):
[in this window]
[in a new window]
 
Figure 3. sGC-, cGMP- and eNOS-IR in the lamina propria of a seminiferous tubule (x820). Peritubular myofibroblasts of two neighboring tubules showed strong IR for the sGC (a). Some myofibroblasts of the peritubular lamina propria also revealed weak cGMP-IR (b). eNOS-IR was detectable in a great number of lamina propria cells (c). Seminiferous tubules are marked by T and peritubular myofibroblasts by arrows.

 
Strong eNOS-IR was seen in a great number of myofibroblasts of the peritubular lamina propria (Fig. 3cGo). In contrast, only weak-to-moderate nNOS-IR was found in the lamina propria (not shown). Intensive staining for nNOS was present in endothelial cells of some small vessels (Fig. 4aGo). IR for eNOS was found in endothelial and smooth muscle cells of large blood vessels (Fig. 4bGo and c). The endothelium of small vessels, however, showed only weak eNOS-IR.



View larger version (136K):
[in this window]
[in a new window]
 
Figure 4. IR for nNOS and eNOS in testicular blood vessels. nNOS-IR was present in endothelial cells of a small (diameter < 35 µm) testicular artery (a, x820). Large (diameter >= 55 µm) blood vessels (b, longitudinal section; c, cross-section) showed strong eNOS-IR in endothelial and smooth-muscle cells (x630). The vascular lumen is marked by asterisks, endothelial cells by arrows, and smooth muscle cells by arrowheads.

 
In seminiferous tubules, Sertoli cells also showed weak immunostaining for sGC (Fig. 5aGo), cGMP, eNOS, and nNOS (not shown). Consistent with previous reports (8, 9), specific immunostaining for sGC, cGMP, and nNOS was seen also in Leydig cells.



View larger version (90K):
[in this window]
[in a new window]
 
Figure 5. sGC- and iNOS-IR in Sertoli cells of the human testis. Numerous Sertoli cells of a seminiferous tubule showed moderate sGC-IR (a, x1000), whereas only few Sertoli cells were iNOS-positive (b, x630). The germinal epithelium is indicated by G, the peritubular lamina propria by asterisks, and Sertoli cells by arrows.

 
In contrast to eNOS and nNOS, only a small number of Sertoli cells (Fig. 5bGo), but neither of the other testicular structures, showed any iNOS-IR. In agreement (data not shown), Western blot analyses of vessels and tubules did not reveal iNOS-specific signals.

To assure the validity of the immunochemical data obtained, a variety of control experiments have been performed. Generally, the immunohistochemical and Western blot data presented were representative of independent analyses of at least six testes derived from different patients. For each antigen examined, the specificity of signals was confirmed by negative control reactions in which specific antisera were replaced by either normal rabbit/mouse antisera or purified rabbit/mouse IgGs. Staining specificity was also demonstrated with antisera preincubated with an excess of the corresponding antigens or with cell lysates known to contain the specific antigens (Fig. 6Go). Positive controls corroberated the specificity of the antibody reactions, both by Western Blots in different tissues (Fig. 1Go) and by immunohistochemistry on rat brain sections, where comparable analyses were performed previously (21, 22, 23). Moreover, immunohistochemical results were confirmed by staining procedures on testicular sections with additional antibodies against nNOS, eNOS, iNOS, and cGMP.



View larger version (90K):
[in this window]
[in a new window]
 
Figure 6. Immunohistochemical control experiments (x570). Neither intertubular arteries nor peritubular lamina propria cells showed any staining after preadsorption of anti-sGC (a) and anti-nNOS (b) to an excess of the corresponding antigens. eNOS- and iNOS-IR were not detectable in testis sections after preincubation of anti-eNOS with lysates from endothelial cells (c) and of anti-iNOS with lysates from macrophages (d). Seminiferous tubules are marked by T, the peritubular lamina propria by asterisks, and arteries by arrows.

 
To examine the functional activity of sGC, isolated vessels and tubules were incubated with the NO donor SNP, and the production of cGMP was determined by RIAs (Fig. 7aGo). SNP-induced increases of cGMP were measured in all experiments, and the data revealed [on an average, 47-fold (vessels) and 14-fold (tubules), respectively] stimulations of sGC activity. Note that the extent of sGC stimulation in blood vessels varied considerably among individual preparations, presumably because of differences in diameters of vessels.

Additional studies served to prove the local production of NO in vessels and tubules. For this, cGMP production during incubations, in either the absence or presence of the NOS inhibitor L-NAME, was determined. Addition of the NOS inhibitor decreased cGMP production in both vessels and tubules by 51.6% and 42.6%, respectively (Fig. 7bGo).


    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
This study demonstrates, for the first time, presence and functional activity of components of the NO system in blood vessels and seminiferous tubules of the human testis.

NO is a major endogenous vasodilator (4, 5), and NO-induced increases in cGMP levels correlate with relaxation (reviewed in Ref.25). Therefore, the observed NO-mediated cGMP accumulation by testicular blood vessels and the immunohistochemical localization of sGC and cGMP in vascular smooth muscle cells are indicative of a vasorelaxant function (4). In addition, NO has been shown to influence permeability of vascular endothelial cells (26, 27). However, whether the occurrence of sGC and cGMP in testicular endothelial cells can be explained in this context, remains to be elucidated.

In seminiferous tubules, NO-induced cGMP production may mediate relaxation of myofibroblasts. Whereas endothelin, for example, has been shown to be involved in peritubular cell contraction in the rat (28), the agents responsible for relaxation have not yet been defined. Peritubular myofibroblasts express filaments characteristic of fibroblasts and smooth muscle cells (14, 19). An influence of NO on myofibroblasts may be postulated in context of the well-known NO effects on smooth muscle cells in other organs (6). In the peritubular lamina propria, NO may participate in the regulation of the peristaltic activity of the tubules, which in turn, is necessary for sperm transport (16). Furthermore, NO may influence the permeability of the lamina propria and, by this, the transport of nutrients into the tubular lumen (19).

Our findings that NOS is present and functionally active in testicular blood vessels and seminiferous tubules refers to a local production of NO in these structures. Thus, physiological effects on vessels and tubules may be elicited by endogenously-produced NO and by NO from neighboring Leydig cells previously shown to express nNOS (10, 11).

Based on our findings that some Sertoli cells show NOS-IR, the NO-induced increases in cGMP production observed in isolated tubules may, in part, be caused by NO produced by Sertoli cells. Thus, NO derived from these cells may contribute also to the presumed relaxation of lamina propria cells. However, the reported NO effects on sperm cells after spermiation (29, 30), cells which are devoid of NOS activity (31, 32), point to additional or alternative functions of Sertoli cell-produced NO.

The expression of the two NOS isoforms, nNOS and eNOS, in blood vessels and seminiferous tubules is a notable observation. Recent analyses of mutant mice with targeted disruptions of either the neuronal (23, 33) or the endothelial NOS gene (34) suggested that eNOS-produced NO may be involved in dilatation of blood vessels, whereas nNOS-derived NO might contribute to vasoconstriction in brain (33). It will be of particular interest to investigate whether there also is a functional heterogeneity of the two NOS subtypes in the testis.

IR for the third NOS isoform, iNOS, was not detected in blood vessels and lamina propria cells. However, a minority of Sertoli cells showed iNOS-IR. In this context, it should be noted that a measurable iNOS gene expression by isolated rat Sertoli cells was described to depend on induction by cytokines (35).

Taken together, our results demonstrate that testicular vasculature and seminiferous tubules are sites of NO production and activity (Fig. 8Go). It is an attractive idea that NO acts locally to regulate the distribution of oxygen, nutrients, and hormones by testicular vessels, as well as the peristaltic activity of tubules in context of sperm transport.



View larger version (80K):
[in this window]
[in a new window]
 
Figure 8. Schematic presentation of the presumed NO systems in Leydig cells, testicular blood vessels, and seminiferous tubules. Possible sites of NO production (occurrence of NOS) and activity (occurrence of sGC) are indicated. Physiological effects may include an influence on testosterone production by Leydig cells (11–13), relaxation of peritubular myofibroblasts, and dilatation of testicular blood vessels. Because NO can freely diffuse across membranes (indicated by + signs), the three different systems may influence one another.

 


    Acknowledgments
 
We are grateful to S. Giehler, M. Schwartz, and S. Schwartz for their excellent technical assistance. Furthermore, we are indebted to Dr. D. Koesling and to Dr. J. DeVente, who donated the anti-sGC and the anti-cGMP antiserum, respectively.


    Footnotes
 
1 This study was supported by grants from the Deutsche Forschungsgemeinschaft (Ho 388/6–3) and the Bundesministerium für Bildung, Wissenschaft, Forschung und Technologie, as a part of a larger concerted project "Fertilitätsstörungen" (01KY 9502). Back

Received October 28, 1996.

Revised February 25, 1997.

Revised July 9, 1997.

Accepted August 14, 1997.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Koesling D, Böhme E, Schulz G. 1991 Guanylyl cyclases, a growing family of signal-transducing enzymes. FASEB J. 5:2785–2791.[Abstract]
  2. Snyder SH. 1992 Nitric oxide: first in a new class of neurotransmitters? Science. 257:494–496.[Free Full Text]
  3. Bredt DS, Snyder SH. 1994 Nitric oxide: a physiological messenger molecule. Annu Rev Biochem. 63:175–195.[CrossRef][Medline]
  4. Inagami T, Naruse M, Hoover R. 1995 Endothelium as an endocrine organ. Annu Rev Physiol. 57:171–189.[CrossRef][Medline]
  5. Moncada S, Palmer RMJ, Higgs EA. 1991 Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev. 43:109–142.[Medline]
  6. Schmidt HHW, Walter U. 1994 NO at work. Cell. 78:919–925.[CrossRef][Medline]
  7. Förstermann U, Closs EI, Pollock JS, et al. 1994 Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions. Hypertension. 23:1121–1131.[Abstract/Free Full Text]
  8. Ehren I, Adolfsson J, Wiklund NP. 1994 Nitric oxide synthase activity in the human urogenital tract. Urol Res. 22:287–290.[CrossRef][Medline]
  9. Burnett AL, Ricker DD, Chamness SL, et al. 1995 Localization of nitric oxide synthase in the reproductive organs of the male rat. Biol Reprod. 52:1–7.[Abstract]
  10. Davidoff MS, Middendorff R, Mayer B, Holstein AF. 1995 Nitric oxide synthase (NOS-I) in Leydig cells of the human testis. Arch Histol Cytol. 58:17–30.[Medline]
  11. Davidoff MS, Middendorff R, Mayer B, de Vente J, Koesling D, Holstein AF. 1997 Nitric oxide/cGMP-pathway components in Leydig cells of the human testis. Cell Tissue Res. 287:161–170.[CrossRef][Medline]
  12. Adams ML, Meyer ER, Sewing BN, Cicero JT. 1994 Effects of nitrc oxide-related agents on rat testicular function. J Pharmacol Exp Ther. 269:230–237.[Abstract/Free Full Text]
  13. Welch C, Watson ME, Poth M, Hong T, Francis GL. 1995 Evidence to suggest nitric oxide is an interstitial regulator of Leydig cell steroidogenesis. Metabolism. 44:234–238.[CrossRef][Medline]
  14. Davidoff MS, Breucker H, Holstein AF, Seidl K. 1990 Cellular architecture of the lamina propria of human seminiferous tubules. Cell Tissue Res. 262:253–261.[CrossRef][Medline]
  15. Ergün S, Stingl J, Holstein AF. 1994 Microvasculature of the human testis in correlation to Leydig cells and seminiferous tubules. Andrologia. 26:255–262.[Medline]
  16. Setchell BP, Maddocks S, Brooks DE. 1994 Anatomy, vasculature, innervation, and fluids of the male reproductive tract. In: Knobil E, Neill JD, eds. The physiology of reproduction. 2nd ed. New York: Raven Press; 1063–1175.
  17. Ross MH, Long JR. 1966 Contractile cells in human seminiferous tubules. Science. 153:1271–1273.[Abstract/Free Full Text]
  18. DeKretser DM, Kerr JB, Paulsen CA. 1975 The peritubular tissue in the normal and pathological human testis. An ultrastructural study. Biol Reprod. 12:317–324.[Abstract]
  19. Holstein AF, Maekawa M, Nagano T, Davidoff MS. 1996 Myofibroblasts in the lamina propria of human seminiferous tubules are dynamic structures of heterogenous phenotype. Arch Histol Cytol. 59:109–125.[Medline]
  20. Seidl K, Holstein AF. 1990 Organ culture of human seminiferous tubules: a useful tool to study the role of nerve growth factor in the testis. Cell Tissue Res. 261:539–547.[CrossRef][Medline]
  21. DeVente J, Steinbusch HWM. 1992 On the stimulation of soluble and particulate guanylate cyclase in the rat brain and the involvement of nitric oxide as studied by cGMP immunocytochemistry. Acta Histochem. 92:13–38.[Medline]
  22. Schmidt HHHW, Gagne GD, Nakane M, Pollock JS, Miller MF, Murad F. 1992 Mapping of neural nitric oxide synthase in the rat suggests frequent colocalization with NADPH diaphorase but not with soluble guanylate cyclase, and novel paraneural functions for nitrinergic signal transduction. J Histochem Cytochem. 40:1439–1456.[Abstract]
  23. Irikura K, Huang PL, Ma J, et al. 1995 Cerebrovascular alterations in mice lacking neuronal nitric oxide synthase gene expression. Proc Natl Acad Sci USA. 92:6823–6827.[Abstract/Free Full Text]
  24. Mukhopadhyay AK, Schumacher M, Leidenberger FA. 1986 Steroidogenic effect of atrial natriuretic factor in isolated mouse Leydig cells is mediated by cyclic GMP. Biochem J. 239:463–467.[Medline]
  25. Drewett JG, Garbers DL. 1994 The family of guanylyl cyclase receptors and their ligands. Endoc Rev. 15:135–162.[CrossRef][Medline]
  26. Noel AA, Fallek SR, Hobson RW, Duran WN. 1995 Inhibition of nitric oxide synthase attenuates primed microvascular permeability in the in vivo microcirculation. J Vasc Surg. 22:661–670.[CrossRef][Medline]
  27. Rumbaut RE, McKay MK, Huxley VH. 1995 Capillary hydraulic conductivity is decreased by nitric oxide synthase inhibition. Am J Physiol. 268:H1856–H1861.
  28. Tripiciano A, Filippini A, Giustiniani Q, Palombi F. 1996 Direct visualization of rat peritubular myoid cell contraction in response to endothelin. Biol Reprod. 55:25–31.[Abstract]
  29. Rosselli M, Dubey RK, Imthurn B, Macas E, Keller PJ. 1995 Effects of nitric oxide on human spermatozoa: evidence that nitric oxide decreases sperm motility and induces sperm toxicity. Hum Reprod. 10:1786–1790.[Abstract/Free Full Text]
  30. Weinberg JB, Doty E, Bonaventura J, Haney AF. 1995 Nitric oxide inhibition of human sperm motility. Fertil Steril. 64:408–413.[Medline]
  31. Zini A, de Lamirande E, Gagnon C. 1995 Low levels of nitric oxide promote human sperm capacitation in vitro. J Androl. 16:424–431.[Abstract/Free Full Text]
  32. Schaad NC, Zhang XQ, Campana A, Schorderet-Slatkine S. 1996 Human seminal plasma inhibits brain nitric oxide synthase activity. Hum Reprod. 11:561–565.
  33. Huang Z, Huang PL, Panahian N, Dalkara T, Fishman MC, Moskowitz MA. 1994 Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science. 265:1883–1885.[Abstract/Free Full Text]
  34. Huang PL, Huang Z, Mashimo H, et al. 1995 Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature. 377:239–242.[CrossRef][Medline]
  35. Stephan JP, Guillemois C, Jegou B, Bauche F. 1995 Nitric oxide production by Sertoli cells in response to cytokines and lipopolysaccharide. Biochem Biophys Res Commun. 213:218–224.[CrossRef][Medline]



This article has been cited by other articles:


Home page
EndocrinologyHome page
C. Schell, M. Albrecht, C. Mayer, J. U. Schwarzer, M. B. Frungieri, and A. Mayerhofer
Exploring Human Testicular Peritubular Cells: Identification of Secretory Products and Regulation by Tumor Necrosis Factor-{alpha}
Endocrinology, April 1, 2008; 149(4): 1678 - 1686.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
Y. Kondo, T. Ishikawa, K. Yamaguchi, T. Yada, and M. Fujisawa
Oral Administration of Tetrahydrobiopterin Attenuates Testicular Damage by Reducing Nitric Oxide Synthase Activity in a Cryptorchid Mouse Model
J Androl, March 1, 2008; 29(2): 153 - 163.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Mewe, I. Wulfsen, A. M. E. Schuster, R. Middendorff, G. Glassmeier, J. R. Schwarz, and C. K. Bauer
Erg K+ channels modulate contractile activity in the bovine epididymal duct
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2008; 294(3): R895 - R904.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
M. Mewe, I. Wulfsen, R. Middendorff, and C. K Bauer
Differential modulation of bovine epididymal activity by oxytocin and noradrenaline
Reproduction, September 1, 2007; 134(3): 493 - 501.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
A. Jankowska, B. Burczynska, T. Duda, J. B. Warchol, and R. K. Sharma
Calcium-Modulated Rod Outer Segment Membrane Guanylate Cyclase Type 1 Transduction Machinery in the Testes
J Androl, January 1, 2007; 28(1): 50 - 58.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
M. Mewe, C. K. Bauer, J. R. Schwarz, and R. Middendorff
Mechanisms Regulating Spontaneous Contractions in the Bovine Epididymal Duct
Biol Reprod, October 1, 2006; 75(4): 651 - 659.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Mewe, C. K. Bauer, D. Muller, and R. Middendorff
Regulation of Spontaneous Contractile Activity in the Bovine Epididymal Duct by Cyclic Guanosine 5'-Monophosphate-Dependent Pathways
Endocrinology, April 1, 2006; 147(4): 2051 - 2062.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
N. P.Y. Lee, D. D. Mruk, C.-h. Wong, and C. Y. Cheng
Regulation of Sertoli-Germ Cell Adherens Junction Dynamics in the Testis Via the Nitric Oxide Synthase (NOS)/cGMP/Protein Kinase G (PRKG)/{beta}-Catenin (CATNB) Signaling Pathway: An In Vitro and In Vivo Study
Biol Reprod, September 1, 2005; 73(3): 458 - 471.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
F. Shi and T. Wang
Stage- and Cell-Specific Expression of Soluble Guanylyl Cyclase Alpha and Beta Subunits, cGMP-Dependent Protein Kinase I Alpha and Beta, and Cyclic Nucleotide-Gated Channel Subunit 1 in the Rat Testis
J Androl, March 1, 2005; 26(2): 258 - 263.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
T. Ishikawa, Y. Kondo, K. Goda, and M. Fujisawa
Overexpression of Endothelial Nitric Oxide Synthase in Transgenic Mice Accelerates Testicular Germ Cell Apoptosis Induced by Experimental Cryptorchidism
J Androl, March 1, 2005; 26(2): 281 - 288.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
D. Muller, A. K. Mukhopadhyay, R. C. Speth, G. Guidone, R. Potthast, L. R. Potter, and R. Middendorff
Spatiotemporal Regulation of the Two Atrial Natriuretic Peptide Receptors in Testis
Endocrinology, March 1, 2004; 145(3): 1392 - 1401.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
N. P.Y. Lee and C. Y. Cheng
Nitric Oxide/Nitric Oxide Synthase, Spermatogenesis, and Tight Junction Dynamics
Biol Reprod, February 1, 2004; 70(2): 267 - 276.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
N. P. Y. Lee and C. Yan Cheng
Regulation of Sertoli Cell Tight Junction Dynamics in the Rat Testis via the Nitric Oxide Synthase/Soluble Guanylate Cyclase/3',5'-Cyclic Guanosine Monophosphate/Protein Kinase G Signaling Pathway: an in Vitro Study
Endocrinology, July 1, 2003; 144(7): 3114 - 3129.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
C. Romeo, R. Ientile, P. Impellizzeri, N. Turiaco, M. Teletta, P. Antonuccio, M. Basile, and C. Gentile
Preliminary report on nitric oxide-mediated oxidative damage in adolescent varicocele
Hum. Reprod., January 1, 2003; 18(1): 26 - 29.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
A. Revelli, D. Ghigo, F. Moffa, M. Massobrio, and I. Tur-Kaspa
Guanylate Cyclase Activity and Sperm Function
Endocr. Rev., August 1, 2002; 23(4): 484 - 494.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. Middendorff, D. Muller, M. Mewe, A. K. Mukhopadhyay, A. F. Holstein, and M. S. Davidoff
The Tunica Albuginea of the Human Testis Is Characterized by Complex Contraction and Relaxation Activities Regulated by Cyclic GMP
J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3486 - 3499.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
Y. Wang, D. C. Newton, T. L. Miller, A.-M. Teichert, M. J. Phillips, M. S. Davidoff, and P. A. Marsden
An Alternative Promoter of the Human Neuronal Nitric Oxide Synthase Gene Is Expressed Specifically in Leydig Cells
Am. J. Pathol., January 1, 2002; 160(1): 369 - 380.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
K. Shiraishi, K. Naito, and K.-i. Yoshida
Nitric Oxide Promotes Germ Cell Necrosis in the Delayed Phase after Experimental Testicular Torsion of Rat
Biol Reprod, August 1, 2001; 65(2): 514 - 521.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
C. Battaglia, S. Giulini, G. Regnani, R. Di Girolamo, S. Paganelli, F. Facchinetti, and A. Volpe
Seminal plasma nitrite/nitrate and intratesticular Doppler flow in fertile and infertile subjects
Hum. Reprod., December 1, 2000; 15(12): 2554 - 2558.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
R. Middendorff, M. Kumm, M. S. Davidoff, A. F. Holstein, and D. Müller
Generation of Cyclic Guanosine Monophosphate by Heme Oxygenases in the Human Testis--A Regulatory Role for Carbon Monoxide in Sertoli Cells?
Biol Reprod, August 1, 2000; 63(2): 651 - 657.
[Abstract] [Full Text]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Middendorff, R.
Right arrow Articles by Davidoff, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Middendorff, R.
Right arrow Articles by Davidoff, M. S.